Mandate Vinge advised Forbion Capital Partners in connection with investment in Cadoz AB

May 10, 2010

Cardoz AB based in Stockholm has received a capital injection of SEK 100 million. The investment has been made by the Dutch venture capital company, Forbion Capital Partners and the Spanish venture capital company, Ysios Capital Partners together with the existing owner the Swedish venture capital company, HealthCap, which also helped to start the company.

Cardoz develops anti-inflammatory pharmaceuticals to combat heart and vascular disorders. The capital contribution is primarily intended for the execution of a clinical phase II trial of a new drug to combat abdominal aorta aneurism (AAA). At present there are no drugs which combat AAA.

Vinge’s team consisted of responsible partner Johan Winnerblad and Johan Larsson who acted as project manager.

Summary of employment related news in Sweden as of January 2021

Short-time work, a new pandemic law and pending changes to the Employment Protection Act. Here is the latest employment related news in Sweden.
January 19, 2021

Sanctions round-up

Not so long ago, sanctions were a rare occurrence which only involved obscure products and countries, and which were decided by the members of the United Nations Security Council. Today, the European Union and particularly the United States, impose sanctions and other trade restrictions with high frequency which have the potential to affect any type of transaction. Set forth below is a summary of some recent developments.
December 22, 2020